Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer

Diseases of the Esophagus

Volumn 18, Issue 4, 2005, Pages 215-220

  Yamashita, H ^a   Nakagawa, K ^a   Tago, M ^a   Nakamura, N ^a   Shiraishi, K ^a   Ohtomo, K ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Esophageal cancer; Radiotherapy; Recurrence; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN; STEROID; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MALE; MEDIASTINUM CANCER; METASTASIS; NERVE PARALYSIS; PLEURA EFFUSION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION RESPONSE; RECURRENT DISEASE; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; ADJUVANT CHEMOTHERAPY; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FOLLOW UP; MEDIASTINUM TUMOR; MIDDLE AGED; PALLIATIVE THERAPY; REMISSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33644811796     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00502.x     Document Type: Article

References (14)

1. Bhansali M S, Fujita H, Kakegawa T et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997; 21: 275-81.
2. Collard J M, Otte J B, Reynaert M S et al. Extensive lymph node clearance for cancer of the esophagus or cardia: Merits and limits in reference to 5-year absolute survival. Hepatogastroenterology 1995; 42: 619-27.
3. Tam P C, Siu K F, Cheung H C et al. Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg 1987; 205: 189-94.
4. Raoul J L, Le Prise E, Meunier B et al. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995; 37: 174-6.
5. Miller A B, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
6. National Cancer Institute Common Toxicity Criteria (NCI-CTC) Version 2.0, April 1999; 30.
7. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/ or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
8. Nishimura Y, Suzuki M, Nakamatsu K et al. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002; 53: 134-9.
9. Sakai K, Inakoshi H, Sueyama H et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 921-7.
10. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
11. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An Intergroup study. J Clin Oncol 1997; 15: 277-84.
12. Smith T J, Ryan L M, Douglass H O Jr. et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 269-76.
13. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
14. Nemoto K, Ariga H, Kakuto Y et al. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiotherapy Oncol 2001; 61: 165-8.